H-1B sponsorship profile: Chartwell Pharmaceuticals, LLC. Across U.S. Department of Labor LCA disclosures, Chartwell Pharmaceuticals, LLC filed 10 Labor Condition Applications covering 10 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (10 certified of 10 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Chartwell Pharmaceuticals, LLC’s H-1B petitions range from $59,197 at the low end to $272,538 at the high end, with a petition-weighted average of $125,649. That range reflects the mix of occupations the company sponsors, led by Regulatory Affairs Associate (2 petitions at $59,197 avg), followed by Vice President - Research and Development and VICE PRESIDENT - RESEARCH AND DEVELOPMENT. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Chartwell Pharmaceuticals, LLC is headquartered in CONGERS, NY under NAICS code 32541, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Chartwell Pharmaceuticals, LLC ranks. By H-1B petition volume, Chartwell Pharmaceuticals, LLC is #16,610 of 119,880 employers nationally and #1,422 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.